This Tiny Biotech Stock Is About to Go Ballistic

You are receiving this message as a subscriber of Trading Tips. This is a paid advertisement. Claims have not been independently verified.   Dear Reader,  Big Pharma is on the cusp of annihilation.  The dominance of behemoth pharmaceutical companies is about to come to an abrupt halt.  You see, while thousands of biotech companies have been shooting for billion-dollar drugs … vaccinations … and medical devices …   This tiny biotech stock is poised to annihilate big pharma. An innovative Midwestern firm has taken a much different route.  It is reinventing healthcare from the nucleus up … and will soon dominate this $1.7 trillion industry.  The dean of Stanford’s School of Medicine says: “The opportunities are enormous” … vice chair at Duke University’s Department of Surgery declares this is “changing the game” … and a University of Pennsylvania Wharton School of Business study calls this breakthrough “a revolutionary approach to tackling disease.” And early investors will have the opportunity to make an absolute fortune.  Full details are here…  Jeff Yastine Editorial Director, Banyan Hill Publishing From time to time your free Trading Tips newsletter subscription is supplemented by paid sponsorships, like the one above. Please read all disclaimers. Rest assured that your information was not shared with this sponsor. Please note that Trading Tips has not independently reviewed the validity of the claims or statements contained within this sponsorship, and we are not responsible for any errors or omissions. Never invest in a security or idea featured on our site or in our emails unless you can afford to lose your entire investment. We are not registered investment advisors or brokers/dealers and we do not purport to be. We make no representations, warranties or guarantees as to the accuracy or completeness of the content featured on our site or in our emails. Furthermore, the article authors and contributors featured on this site may own securities mentioned in their articles and not disclose this information. Trading Tips does not endorse any investing or trading products or newsletters advertised in this email or on our web site. Please be sure to read our Terms & Conditions, Disclaimer and Privacy Policy. Go here to get more information from http://www.TradingTips.com     Trading Tips' parent company was recently selected as one of America's fastest-growing private companies.

This email was sent to indra21poetra@gmail.com by manny@wealthpire.com
You were added to the system August 31, 2017.
For more information click here.

Trading Tips | 3435 Ocean Park Blvd. Suite 107-334 | Santa Monica, CA 90405

Unsubscribe | Forward to a Friend | Report Spam